GK: 3rd Quarter 2023 Portfolio Review

Performance data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Investment return and principal value will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than original cost. Returns less than one year are not annualized. For the fund’s most recent standardized and month-end performance, please click www.advisorshares.com/etfs/gk.


The third quarter of 2023 started off with a bang with the AdvisorShares Gerber Kawasaki ETF (GK) reaching a high for the year ($19 NAV) during the middle of July. This strong performance for the fund continued for the first seven months of the year, but then things changed. The Federal Reserve’s (Fed) continued assault on asset values accelerated with the long-term Treasury rate moving up more than 100 basis points (1%) in August and September – bringing the 10-year rates from below 4% to almost 5%. As one might expect, this created a lot of pressure on GK’s portfolio, as it did in 2022, as rapidly rising rates hurts growth companies and makes financial conditions much more challenging for small and mid-sized businesses. Even though inflation has declined substantially from the highs of 2022, the Fed continues to talk down asset values and talk up rates in, what we believe, is a misguided view that inflation is not under control. In fact, the markets have become quite fearful the Fed has gone too far and will drive the economy into a recession in early 2024. We heard this at the end of last year, causing investors to fear a recession in the second half of 2023 which never materialized. In fact, we just saw a period of growth on top of much lower inflation which drove higher consumer spending and, so far, solid earnings for Q3.

With the cross current of a stronger economy – despite higher rates and a Fed that will seemingly never go away – investors moved to the sidelines in droves in August and September. The other challenging part for GK’s portfolio is our thematic approach to investing which includes climate change investments like Tesla and others. These businesses are interest rate sensitive – the nature of buying electric vehicles, solar and battery systems are all used with borrowed money. Many construction projects, which would normally be investing to build housing, cannot afford to borrow at the in the current interest rate environment; therefore future construction is down substantially. We fear that the Fed doesn’t understand the long-term consequences of raising rates so rapidly as loans mature: businesses and individuals loans that must be refinanced at substantially higher costs cause financial distress to anybody caught in this situation, including the US government itself!

These conditions have forced us to lower or sell off positions in our climate portfolio because of the rapid declining values caused by higher rates. The consumer area of our portfolio has performed much better as it has been stronger. New additions like Lululemon continue to show strong sales. The technology portion of our portfolio has also been strong, led by companies like Microsoft and Netflix which performed very well despite the headwinds. We’ve had a lot of success with Novo Nordisk, thanks to its weight loss drugs like Ozempic, and Nvidia, our top chip holding which is a leader in AI. We’ve exited all commodity positions and have lowered the number of holdings in the fund to concentrate in our best positions. Also, because the high-rate environment is creating a very difficult environment for smaller businesses, we’ve lowered or exited positions that were more speculative.

At this point, until we get more certainty in our belief that the Fed is done raising interest rates, it is just a waiting game. As we move into 2024, we believe the economy will weaken and the Fed will be forced to lower rates to a much more accommodating level. We believe the economy will be stronger than what people expect and don’t expect a recession as the Fed will create lots of liquidity by ending their rate tightening cycle. Certainly, any signal that the Fed is done raising rates will cause investors to move from short term funds to longer term treasuries to lock in these higher rates. Then we believe a real rally in the types of assets the GK fund owns will truly begin. Year to date through September, we’ve had a decent year with the fund up over 9% (NAV and market) but certainly have given back a large amount of our gains as we were up about 24% in the middle of July. I am confident that we are close to the end of this extremely long rate hike cycle and GK’s assets will recover value very rapidly. Investors need to be patient and wait for the moment when we have more certainty. Thank you for your patience during these two long years of interest rate hikes and I have every confidence that our fund will recover value upon normalization of our economy and rates.

Top Holdings

Ticker Security Description Portfolio Weight %

As of 09.30.2023. Cash is not included. Subject to change.  


Ross Gerber | Gerber Kawasaki | President and CEO
AdvisorShares Gerber Kawasaki ETF (GK) Portfolio Manager


The S&P 500 Index is a broad-based, unmanaged measurement of changes in stock market conditions based on the average of 500 widely held common stocks. One cannot invest directly in an index.


Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information is in the prospectus, a copy of which may be obtained by visiting www.advisorshares.com. Please read the prospectus carefully before you invest. Foreside Fund Services, LLC, distributor.

There is no guarantee that the Fund will achieve its investment objective. An investment in the Fund is subject to risk, including the possible loss of principal amount invested. Investing in mid and small capitalization companies may be riskier and more volatile than large cap companies. Because it intends to invest in value stocks, the Fund could suffer losses or produce poor results relative to other funds, even in a rising market, if the Sub-Advisor’s assessment of a company’s value or prospects for exceeding earnings expectations or market conditions is incorrect. Other Fund risks include market risk, equity risk, large cap risk, liquidity risk and trading risk. Please see prospectus for details regarding risk. 

Investing involves risk including possible loss of principal. The Sub-Advisor’s judgment about the markets, the economy, or companies may not anticipate actual market movements, economic conditions or company performance, and these factors may affect the return on your investment. When models and data prove to be incorrect or incomplete, any decisions made in reliance thereon expose the Fund to potential risks. In addition, the use of predictive models has inherent risk. Because predictive models are usually constructed based on historical data supplied by third parties, the success of relying on such models may depend heavily on the accuracy and reliability of the supplied historical data. The prices of growth stocks are based largely on projections of the issuer’s future earnings and revenues. If a company’s earnings or revenues fall short of expectations, its stock price may fall dramatically.

Companies involved in the cannabis industry face competition, may have limited access to banks, limited resources due to litigation and are dependent on receiving necessary permits and authorizations to engage in medical cannabis research or to cultivate, possess or distribute cannabis. The possession and use of cannabis, even for medical purposes, is illegal under federal and certain states’ laws, which may negatively impact the value of the Fund’s investments.

The value of stocks of technology companies tend to be more volatile than the overall market and are vulnerable to rapid changes in technology, rapid product obsolescence, the loss of patent, copyright and trademark protections and government regulation and competition. The expansion of online gambling (both regulated and unregulated), including the award of additional licenses or expansion or relocation of existing gambling companies, and competition from other leisure and entertainment activities, could impact these companies’ finances. Companies within the biotech industry invest heavily in research and development, which may not lead to commercially successful products.

Diversification does not guarantee favorable returns. While the fund invests across multiple thematic trends it is considered a “non-diversified fund” under federal law, the Fund may invest a greater percentage of its assets in a particular issuer and hold a smaller number of portfolios securities.

Shares are bought and sold at market price (closing price) not NAV and are not individually redeemed from the Fund. Market price returns are based on the midpoint of the bid/ask spread at 4:00 pm Eastern Time (when NAV is normally determined), and do not represent the return you would receive if you traded at other times.

Holdings and allocations are subject to risks and to change.

The views in this commentary are those of the portfolio manager and may not reflect his views on the date this material is distributed or anytime thereafter. These views are intended to assist shareholders in understanding their investments and do not constitute investment advice.